Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories property, Plant & Equipment — Gross Carrying Value ($M) ($M)
Form 10-K / 10-Q Supplemental Financial Information Footnote & Item 2 (Properties)
Latest, FY2025
25,222
Period ended Dec 31, 2025
Change on a year earlier
+10.9%
22,740 in FY2024
History
13 years
Since FY2013
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Property, Plant & Equipment — Gross Carrying Value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 25,222 | +10.9% | SEC Filing (0001628280-26-050134) ↗ |
| FY2024 | Dec 31, 2024 | 22,740 | +3.7% | SEC Filing (0001628280-26-010185) ↗ |
| FY2023 | Dec 31, 2023 | 21,933 | +8.5% | SEC Filing (0001628280-25-007110) ↗ |
| FY2022 | Dec 31, 2022 | 20,212 | +4.4% | SEC Filing (0001628280-24-005348) ↗ |
| FY2021 | Dec 31, 2021 | 19,364 | +3.0% | SEC Filing (0001628280-23-004026) ↗ |
| FY2020 | Dec 31, 2020 | 18,793 | +11.9% | SEC Filing (0001104659-22-025141) ↗ |
| FY2019 | Dec 31, 2019 | 16,799 | +7.0% | SEC Filing (0001104659-21-025751) ↗ |
| FY2018 | Dec 31, 2018 | 15,706 | +2.9% | SEC Filing (0001104659-20-023904) ↗ |
| FY2017 | Dec 31, 2017 | 15,265 | +23.4% | SEC Filing (0001047469-19-000624) ↗ |
| FY2016 | Dec 31, 2016 | 12,366 | -0.1% | SEC Filing (0001047469-18-000856) ↗ |
| FY2015 | Dec 31, 2015 | 12,383 | -2.0% | SEC Filing (0001047469-17-000744) ↗ |
| FY2014 | Dec 31, 2014 | 12,632 | -1.8% | SEC Filing (0001047469-16-010246) ↗ |
| FY2013 | Dec 31, 2013 | 12,870 | – | SEC Filing (0001047469-15-001377) ↗ |
Breakdown
What makes up property, plant & equipment — gross carrying value ($m)
- Machinery & Equipment — Gross ($M)17,571 · FY2025
- Buildings — Gross ($M)4,543 · FY2025
- Construction in Progress ($M)2,567 · FY2025
- Land ($M)541 · FY2025
- Accumulated Depreciation ($M)13,406 · FY2025
- Global Manufacturing Facilities — Worldwide Total (Sites)89 · FY2025
- Owned & Leased Facilities Total Floor Area (Million Sq. Ft.)44 · FY2025
- Share of Total Facilities Floor Area Owned by Abbott (%)65.0% · FY2025
Cite this data
StockData. (2026). Abbott Laboratories Property, Plant & Equipment — Gross Carrying Value ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/xbrl-ppe-gross
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.